A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia

Giovanni Landoni; Lorenzo Piemonti; Antonella d’Arminio Monforte; Paolo Grossi; Alberto Zangrillo; Enrico Bucci; Marcello Allegretti; Giovanni Goisis; Elizabeth M. Gavioli; Neal Patel; Maria De Pizzol; Georgea Pasedis; Flavio Mantelli

A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia

Infectious Diseases and Therapy (2022) - Comments
pubmed: 35618953 doi: 10.1007/s40121-022-00644-6 issn: 2193-8229 issn: 2193-6382

Giovanni Landoni, Lorenzo Piemonti, Antonella D’Arminio Monforte, Paolo Grossi, Alberto Zangrillo, Enrico Bucci, Marcello Allegretti, Giovanni Goisis, Elizabeth M. Gavioli, Neal Patel, Maria De Pizzol, Georgea Pasedis, Flavio Mantelli

Go to article
Go to preprint

Springer Science and Business Media LLC